DanDrit Biotech USA, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 6/16/2017
Contact Info
  • Stumpedyssevej 17
  • Horsholm 2970
  • Denmark

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-K
CIK 0001527728
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2011
Employees 3 a/o Dec 23, 2016
Company Officers/Contacts
Eric Leire CEO
Robert E. Wolfe CFO
Company Directors
Henrik Grønfeldt-Sørensen
Eric Leire
Rene Sindlev
Robert E. Wolfe
Service Providers
Accounting/Auditing Firm
Gregory & Associates, LLC
19 120th Street
Ocean City, MD, 21842
United States
Securities Counsel
K&L Gates LLP OTCQX Sponsor
200 S. Biscayne Blvd
Suite 3900
Miami, FL, 33131
United States
Investor Relations Firm
Wolfe Axelrod Weinberger Associates, LLC
One Grand Central Place
60 East 42nd Street
Suite 2534
New York, NY, 10165
United States
DDRT Security Details
Share Structure
Market Value1 $53,537,398 a/o Oct 20, 2017
Authorized Shares 100,000,000 a/o Sep 28, 2016
Outstanding Shares 13,727,538 a/o Sep 28, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 7,402,528 a/o Sep 28, 2016
Par Value Not Available
Shareholders of Record 75 a/o Sep 28, 2016
Short Selling Data
Short Interest 1,413 (100%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security